Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid

NCT00525616 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Hospital, Rouen